✦ LIBER ✦

P.1.315: THERAPY-RELATED ADVERSE EVENTS IN CROHN'S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY

✍ Scribed by W. Fries; M. Mastronardi; M. Cappello; L. Grossi; A. Lauria; M. Principi; N. Della Valle; N. Buccianti; G. Costantino; F. Furfaro; A. Alibrandi; A.C. Privitera

Book ID: 118648024
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 136 KB
Volume: 43
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(11)60543-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab therapy in 100 Crohn's diseas

Infliximab therapy in 100 Crohn's disease patients: Clinical efficacy and adverse events

✍ R.J. Farrell; P. Lodhavia; M. Alsahli; S. Shah; P. Michetti; M.A. Peppercorn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Infliximab therapy in 100 Crohn's diseas

Infliximab therapy in 100 Crohn's disease patients: Adverse events and clinical efficacy

✍ Farrell, Richard J.; Lodhavia, Parag J.; Alsahli, Mazen; Shah, Samir A.; Falchuk 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 181 KB

P730 ADVERSE EVENTS AND CO-MEDICATION: A

P730 ADVERSE EVENTS AND CO-MEDICATION: A COMPARISON BETWEEN DUAL- AND TRIPLE-COMBINATION THERAPIES IN GENOTYPE 1 PATIENTS WITH CHRONIC HEPATITIS C

✍ Schott, E.; Schober, A.; Link, R.; Weber, B.; Rieke, A.; Moog, G.; Spengler, U.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P337 TNF-alpha as induction therapy for

P337 TNF-alpha as induction therapy for Crohn's disease: a comparison of adalimumab and infliximab – a prospective observational study in Germany

✍ Bokemeyer, B.; Helwig, U.; Teich, N.; Schmidt, C.; Krummenerl, T.; Rupf, A.-K.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 49 KB